Ozgur Sahin

17PUBLICATIONS
80CO-AUTHORS
Occupational epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Microelectromechanical systems (MEMS)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 15, 2024
Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.

Ozge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam

|Jun 10, 2024
The epithelial adherens junction component PLEKHA7 regulates ECM remodeling and cell behavior through miRNA-mediated regulation of MMP1 and LOX.

Amanda C Daulagala, Metin Cetin, Joyce Nair-Menon

|Mar 18, 2024
Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.

Ozge Saatci, Rashed Alam, Kim-Tuyen Huynh-Dam

|Feb 06, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.

Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer

|Jan 10, 2024
TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness.

Ozge Saatci, Ozgur Sahin

Pageof 3